Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1120 of 1,261
  1. US 6984673

    Dental cement composition

    KURARAY CO., LTD. Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  2. US 6984619

    Method for protection against tumor metastasis formation

    The Board of Regents of the University of Texas System Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  3. US 6984504

    Ebola virion proteins expressed from venezuelan equine encephalitis (VEE) virus replicons

    The United States of America as represented by the Secretary of the Army Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  4. US 6984402

    Chrono delivery formulations and method of treating atrial fibrillation

    Elite Laboratories, Inc. Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  5. US 6984381

    Vaccine for the prevention of bacterial infection of the bovine mammary gland

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  6. US 6984487

    Cystic fibrosis gene

    The Board of Regents Acting For and on Behalf of The University of Michigan Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  7. US 6984388

    Adhesion deficient isolate of Flavobacterium columnare against columnaris disease

    The United States of America, as represented by the Secretary of Agriculture Β· Granted Jan 10, 2006 Β· Expires Jan 5, 2026

    expired
  8. US 6982361

    Method of screening a compound for anxiolytic activity in an Apolipoprotein e knockout animal

    The Regents of the University of California Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  9. US 6982275

    Process for producing optically active sulfoxide derivative

    Takeda Pharmaceutical Company Limited Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  10. US 6982168

    Immortal human prostate epithelial cell lines and clones and their applications in the research and therapy of prostate cancer

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  11. US 6982080

    Hydroxyethyl starchβ€”containing polypeptide compositions

    The Regents of the University of Colorado Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  12. US 6982261

    Cyanopyrroles

    Ligand Pharmaceuticals Incorporated Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  13. US 6982348

    Aminoethanol derivatives

    Takeda Pharmaceutical Company Limited Β· Granted Jan 3, 2006 Β· Expires Dec 29, 2025

    expired
  14. SI 1148873

    HIGHLY PURIFIED ETHYL EPA AND OTHER EPA DERIVATIVES FOR NEUROLOGICAL DISORDERS

    AMARIN NEUROSCIENCE LTD [GB] Β· Granted Dec 31, 2005 Β· Expires Dec 26, 2025

    expired
  15. US 6979549

    Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a CLLD8 protein

    Rigel Pharmaceuticals, Inc. Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  16. US 6979730

    Nucleic acids encoding prostate stem cell antigen

    The Regents of the University of California Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  17. US 6979671

    Cyclosporins for the treatment of immune disorders

    Enanta Pharmaceuticals, Inc. Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  18. US 6979451

    Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use

    The Board of Regents for Oklahoma State University Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  19. US 6979702

    Ionomer composite compositions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  20. US 6979724

    Calcium channel proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  21. US 6979723

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  22. US 6979677

    Inhibition of vascular smooth muscle cell proliferation

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  23. US 6979555

    Hyaluronan receptor for endocytosis

    The Board of Regents of the University of Oklahoma Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired
  24. US 6979563

    Attenuation of tumor growth, metastasis and angiogenesis

    BioMarin Enzymes, Inc. Β· Granted Dec 27, 2005 Β· Expires Dec 22, 2025

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.